Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics

Galjart B et al (2019) Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases. Angiogenesis 22(2):355–368 Buisman FE et al (2022) Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment. Eur J Cancer 168:25–33 Falcao D et al (2018) Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - pushing growth as an independent risk factor for decreased survival. Eur J Surg Oncol 44(8):1212–1219 Fonseca GM et al (2018) Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol. Histopathology 72(3):377–390 van Dam PJ et al (2018) Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy. Semin Cancer Biol 52 Pt 2): 86–93 van Dam PJ et al (2017) International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. Br J Cancer 117(10):1427–1441 Frentzas S et al (2016) Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med 22(11):1294–1302 Hoppener DJ et al (2022) The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases. BMC Cancer 22(1):911 Fleischer JR et al (2023) Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. Mol Cancer 22(1):17 Latacz E et al (2022) Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights. Br J Cancer 127(6):988–1013 Vigano L et al (2014) Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol 21(4):1276–1286 Buisman FE et al (2020) Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases. Clin Exp Metastasis 37(5):593–605 Eefsen RL et al (2016) Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab. Int J Cancer 138(7):1777–1784 Messaoudi N et al (2022) Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns. Br J Cancer 126(9):1329–1338 Nierop PM et al (2022) Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases. J Pathol Clin Res 8(1):48–64 Lambin P et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48(4):441–446 Dalal V et al (2020) Radiomics in stratification of pancreatic cystic lesions: machine learning in action. Cancer Lett 469:228–237 Sun R et al (2018) A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol 19(9):1180–1191 Ganeshan B et al (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 10(1):137–143 Cheng J et al (2019) Prediction of histopathologic growth patterns of Colorectal Liver metastases with a noninvasive imaging method. Ann Surg Oncol 26(13):4587–4598 Latacz E et al (2021) Can medical imaging identify the histopathological growth patterns of liver metastases? Semin Cancer Biol 71:33–41 Starmans MPA et al (2021) Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study. Clin Exp Metastasis 38(5):483–494 Taghavi M et al (2021) Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases. Abdom Radiol (NY) 46(1):249–256 Wei S et al (2021) Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy. Eur J Radiol 142:109863 Cheng J et al (2020) Enhanced Rim on MDCT of Colorectal Liver metastases: Assessment of ability to Predict Progression-Free Survival and Response to Bevacizumab-based chemotherapy. Am J Roentgenol 215(6):1377–1383 van Griethuysen JJM et al (2017) Computational Radiomics System to Decode the Radiographic phenotype. Cancer Res 77(21):e104–e7 Wu J et al (2023) uRP: an integrated research platform for one-stop analysis of medical images. Front Radiol 3:1153784 Hoppener DJ et al (2021) Histopathological growth patterns and Survival after Resection of Colorectal Liver Metastasis: an external validation study. JNCI Cancer Spectr 5:3 Han Y et al (2020) Identification of predominant histopathological growth patterns of colorectal liver metastasis by Multi-habitat and Multi-sequence Based Radiomics Analysis. Front Oncol 10:1363 Zaharia C et al (2022) Histopathological growth pattern in Colorectal Liver Metastasis and the Tumor Immune Microenvironment. Cancers (Basel) 15:1 Chun YS et al (2009) Association of Computed Tomography Morphologic Criteria with Pathologic Response and SurvivalinPatientsTreatedWithBevacizumab for Colorectal Liver metastases. JAMA 02(302):21 Lunevicius R et al (2001) Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer. J Cancer Res Clin Oncol 127(3):193–199 Mentha G et al (2009) Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases. Br J Surg 96(1):95–103 Lazaris A et al (2018) Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies. J Pathol Clin Res 4(3):184–192 Van den Eynde M et al (2018) The link between the Multiverse of Immune Microenvironments in metastases and the survival of Colorectal Cancer patients. Cancer Cell 34(6):1012–1026e3